Editas Medicine Files 8-K on Shareholder Vote Matters
Ticker: EDIT · Form: 8-K · Filed: May 31, 2024 · CIK: 1650664
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: EDIT
TL;DR
Editas Medicine held a shareholder vote, details to follow.
AI Summary
Editas Medicine, Inc. filed an 8-K on May 30, 2024, to report on matters submitted to a vote of its security holders. The filing does not detail the specific matters voted upon or the outcome of the vote.
Why It Matters
This filing indicates that Editas Medicine held a shareholder vote, which could pertain to significant corporate decisions or governance changes.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any immediate financial or operational risks.
Key Players & Entities
- Editas Medicine, Inc. (company) — Registrant
- May 30, 2024 (date) — Date of earliest event reported
- 11 Hurley Street Cambridge , Massachusetts 02141 (address) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Editas Medicine's security holders?
The filing does not specify the exact matters voted upon, only that such matters were submitted.
When did the event reported in the 8-K occur?
The earliest event reported occurred on May 30, 2024.
What is the principal executive office address for Editas Medicine, Inc.?
The principal executive offices are located at 11 Hurley Street, Cambridge, Massachusetts 02141.
What is the Commission File Number for Editas Medicine, Inc.?
The Commission File Number is 001-37687.
What is the IRS Employer Identification No. for Editas Medicine, Inc.?
The IRS Employer Identification No. is 46-4097528.
Filing Stats: 573 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-05-31 16:18:30
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value per share EDIT The Nasdaq St
Filing Documents
- edit-20240530.htm (8-K) — 44KB
- 0001650664-24-000050.txt ( ) — 164KB
- edit-20240530.xsd (EX-101.SCH) — 2KB
- edit-20240530_lab.xml (EX-101.LAB) — 21KB
- edit-20240530_pre.xml (EX-101.PRE) — 12KB
- edit-20240530_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders The Company held its Annual Meeting of Stockholders on May 30, 2024. The following is a summary of matters voted on at that meeting. 1. The Company's stockholders elected Meeta Chatterjee, Ph.D., Andrew Hirsch, and Gilmore O'Neill, M.B., to serve as Class II directors until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified. The results of the stockholders' vote with respect to the election of such Class II directors were as follows: Votes For Votes Withheld Broker Non-Votes Meeta Chatterjee, Ph.D. 32,769,825 8,815,678 17,765,319 Andrew Hirsch 32,759,650 8,825,853 17,765,319 Gilmore O'Neill, M.B. 32,909,172 8,676,331 17,765,319 2. The Company's stockholders approved, on an advisory basis, the compensation paid to its named executive officers. The results of the stockholders' non-binding, advisory vote with respect to compensation paid to the Company's named executive officers were as follows: Votes For Votes Against Votes Abstaining Broker Non-Votes 38,609,828 2,769,887 205,788 17,765,319 3. The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year. The results of the stockholders' vote with respect to such ratification were as follows: Votes For Votes Against Votes Abstaining Broker Non-Votes 57,952,408 362,117 1,036,297 0
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EDITAS MEDICINE, INC. Date: May 31, 2024 By: /s/ Gilmore O'Neill Gilmore O'Neill President & Chief Executive Officer